Article Sidebar
Published:
Nov 14, 2016Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Pharmacist intervention in drug-related problems for patients with cardiovascular diseases in selected community pharmacies in Northern Cyprus
Abstract
Purpose: To investigate the role of the community pharmacist in identifying, preventing and resolving drug related problems (DRPs) encountered by patients, with particular emphasis on cardiovascular drugs in community pharmacies in Northern Cyprus, Turkey.
Methods: A prospective observational study for the assessment of DRPs and pharmacist interventions in cardiovascular diseases patients was conducted over a period of four months at four community pharmacies in North Cyprus. Interventions were then evaluated and classified using the Pharmaceutical Care Network Europe PCNE DRP classification tool V6.2.
Results: It was determined that 63 % of patients requiring intervention had problems related to drug use linked to existing diseases. The most common cause of DRPs was adverse drug reactions (ADR, 54 %), while the most common reason for DRPs in this group, ‘Others’ (54 %), was significantly (p < 0.0001); ‘Others’ included compliance problems and unclassified complaints. All patients were counseled. Sixty three percent of the encountered DRPs were completely resolved after intervention; the outcome of the intervention was unknown in 36 % of the patients, but the problem could not be solved in only 1 %.
Conclusion: Adverse drug reactions are the most common DRPs in patients with cardiovascular disease. Pharmacist intervention is effective in reducing the level of DRPs.
Keywords: Drug related problems (DRPs), Adverse drug reactions (ADRs), Pharmaceutical Care Network Europe (PCNE), Community pharmacists, Intervention, Cardiovascular diseases
